Semantic Scholar uses AI to extract papers important to this topic.
Afatinib-an oral irreversible ErbB family blocker-improves progression-free survival compared with pemetrexed and… Expand PURPOSE
The LUX-Lung 3 study investigated the efficacy of chemotherapy compared with afatinib, a selective, orally bioavailable… Expand BACKGROUND
Resistance to endocrine therapy in breast cancer is associated with activation of the mammalian target of rapamycin… Expand BACKGROUND
Everolimus (RAD001) is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), a therapeutic… Expand Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in… Expand PURPOSE
In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II… Expand BACKGROUND
Oral mucositis is a complication of intensive chemotherapy and radiotherapy with no effective treatment. We tested the… Expand The purpose of this study was to determine oral hygiene habits, denture cleanliness, presence of yeasts and denture stomatitis in… Expand PURPOSE
To explore the relationship between oral mucositis and selected clinical and economic outcomes in blood and marrow… Expand Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive (Stage B2) or had regional nodal… Expand